Intestinal permeability, vitamin A absorption and serum alpha-tocopherol during therapy with gefitinib

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 3, 2010, Pages 180-187

  Melichar, Bohuslav ^a,b   Dvok, Josef ^a   Kalbov, Hana ^a   Hypler, Radomr ^a   Krmov, Lenka ^a   Kaparov, Markéta ^a   Urbnek, Lubor ^a   Solichov, Dagmar ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Lactulose; Retinol; Vitamin E; Xylose

Indexed keywords

ALPHA TOCOPHEROL; GEFITINIB; LACTULOSE; MANNITOL; RETINOL; RETINOL PALMITATE; RETINOL STEARATE; XYLOSE;

ADULT; AGED; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HEAD AND NECK CARCINOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; LUNG NON SMALL CELL CANCER; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; SIDE EFFECT; VITAMIN BLOOD LEVEL;

ADULT; AGED; ALPHA-TOCOPHEROL; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MALE; MIDDLE AGED; PERMEABILITY; QUINAZOLINES; VITAMIN A;

EID: 77951429342     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365511003653581     Document Type: Article

References (45)

1. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008;358:1160-1174
2. Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Mcleod A, Feyereislova A, Dong RP, Baselga J. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer. J Clin Oncol 2003;21:2237-2246
3. Park J, Park BB, Kim JY, Lee SH, Lee SI, Kim HY, Kim JH, Park SH, Lee KE, Park JO, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K. Gefitinib (ZD1839) monotherapy as salvage regimen for previously treated advanced non-small cell lung cancer. Clin Cancer Res 2004;10:4383-4388
4. K im ES, Hirsh V, Mok T, Socinski MA, Gervais R, Wu YL, Li LY, Watkins CL, Sellers MV, Lowe ES, Sun Y, Liao ML, Osterlind K, Reck M, Armour AA, Shepherd FA, Lippman SM, Douillard JY. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. Lancet 2008;372:1809-1818
5. Cohen EEW. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2006;24:2659-2665
6. Segaert S, Van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol 2005; 16:1425-1433
7. Segaert S, Tabernero J, Chosidow O, Dirschka T, Elsner J, Mancini L, Maughan T, Morere JF, Santoro A, Sobrero A, Van Cutsem E, Layton A. Management of skin reaction in cancer patients receiving epidermal growth factor receptor targeted therapies. J Dtsch Dermatol Ges 2005;3:599-606
8. Wei Z, Mengzhao W, Li Z, Longyun L, Xiaoton Z. Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status. BMC Res Notes 2008;1:102
9. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002;34:385-396
10. Melichar B, Dvorak J, Hyspler R, Zadak Z. Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents. Chemotherapy 2005;51:336-338
11. Parrilli G, Iaffaioli RV, Capuano G, Budillon G, Bianco AR. Changes in intestinal permeability to lactulose by cytotoxic chemotherapy. Cancer Treat Rep 1982;66:1435-1436
12. Parrilli G, Iaffaioli RV, Martorano M, Cuomo R, Tafuto S, Zampino MG, Budillon G, Bianco AR. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res 1989;49:3689-3691
13. Kohout P, Cerman J, Bratova M, Zadak Z. Small bowel permeability in patients with cytostatic therapy. Nutrition 1999;15:546-549
14. Daniele B, Secondulfo M, De Vivo R, Pignata S, De Magistris L, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R. Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 2001;32: 228-230
15. Melichar B, Dvorak J, Krcmova L, Hyspler R, Urbánek L, Solichova D. Intestinal permeability and vitamin A absorption in patients with chemotherapy-induced diarrhea. Am J Clin Oncol 2008;31:580-584
16. Basu TK, Donaldson D. Intestinal absorption in heath and disease: micronutrients. Best Pract Res Clin Gastroenterol 2003;17:957-979
17. Debier C, Larondelle Y. Vitamins A and E: metabolism, roles and transfer to offspring. Br J Nutr 2005;93:153-174
18. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 2003;21:2545-2550
19. Erhola M, Nieminen MM, Ojala A. Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study. J Exp Clin Cancer Res 1998;17:325-330 (Pubitemid 29090377)
20. Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 2003;21:927-931
21. Urbanek L, Solichova D, Melichar B, Dvorak J, Svobodova I, Solich P. Optimization and validation of a high performance liquid chromatography method for the simultaneous determination of vitamins A and E human serum using monolithic column and diode-array detection. Anal Chim Acta 2006;573-574:267-72. (Pubitemid 44066934)
22. Urbanek L, Krcmova L, Solichova D, Melichar B, Opletalova V, Solich P. Development and validation of a liquid chromatography method for the simultaneous determination of alphatocopherol, retinol and retinyl esters in human serum using a monolithic column for the monitoring of anticancer therapy side effects. J Sep Sci 2006;29:2485-2493
23. Melichar B, Urbanek L, Krcmova L, Kalabova H, Svobodova I, Dragounova E, Vesely P, Hyspler R, Solichova D. Urinary neopterin in patients with ovarian cancer. Pteridines 2006;17:145-153 (Pubitemid 46446217)
24. Sundstrom GM, Wahlin A, Nordin-Anderson I, Suhr OB. Intestinal permeability in patients with acute myeloid leukemia. Eur J Haematol 1998;61:250-254
25. van der Hulst RRWJ, von Meyenfeldt MF, van Kreel BK, Thunnissen FBJM, Brummer RJM, Arends JW, Soeters PB. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition 1998;14:1-6
26. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108: 1566-1581
27. van Nieuwenhoven MA, de Swart EAM, van Eijk HM, Deutz NEP, Brouns F, Brummer RJM. Effect of pre- and post-absorptive factors on the lactulose/rhamnose gut permeability test. Clin Sci (Lond) 2000;98:349-353
28. Oudemans-van Straaten HM, van der Voort PHJ, Hoek FJ, Bosman RJ, van der Spoel JI, Zandstra DF. Pitfalls in gastrointestinal permeability measurement in ICU patients with multiple organ failure using differential sugar absorption. Intensive Care Med 2002;28:130-138
29. Stewart JSW, Cohen EEW, Licitra L, Van Herpen CML, Khorprasert C, Soulieres D, Vodvarka P, Rischin D, Garin AM, Hirsch FR, Varella-Garcia M, Ghiorghiu S, Hargreaves L, Armour A, Speake G, Swaisland A, Vokes EE. Phase III study of gefitinib 250 compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2009;27:1864-1871
30. Wilson CG, O'Mahony BO, Connolly SM, Cantarini MV, Farmer MR, Dickinson PA, Smith RP, Swaisland HC. Do gastrointestinal transit parameters influence the pharmacokinetics? Int J Pharm 2009;376:7-12
31. Harrison EH, Hussain MM. Mechanisms involved in the intestinal digestion and absorption of dietary vitamin A. J Nutr 2001;131:1405-1408
32. Borel P, Pasquier B, Armand M, Tyssandier V, Grolier P, Alexandre-Gouabau MC, Andre M, Senft M, Peyrot J, Jaussan V, Lairon D, Azais-Braesco V. Processing of vitamin A and E in the human gastrointestinal tract. Am J Physiol Gastroint Liver Physiol 2001;280:G95-G103
33. Kim HS, Arai H, Arita M, Sato Y, Ogihara T, Tamai H, Inoue K, Mino M. Age-related changes of alpha-tocopherol transfer protein expression in rat liver. J Nutr Sci Vitaminol 1996;42:11-18
34. McMillan DC, Talwar D, Sattar N, Underwood M, O Reilly DSJ, McArdle C. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr 2002;21:161-164
35. Mayland C, Allen KR, Degg TJ, Bennet M. Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response. Ann Clin Biochem 2004; 41:138-141
36. McMillan DC, Sattar N, Talwar D, O Reilly J, McArdle CS. Changes in micronutrient concentrations following antiinflammatory treatment in patients with gastrointestinal cancer. Nutrition 2000;16:425-428
37. Faure H, Coudray C, Mousseau M, Ducros V, Douki T, Bianchini F, Cadet J, Favier A. 5-hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Rad Biol Med 1996;20: 979-983
38. Jonas RC, Puckett AB, Jones DP, Griffith DP, Szeszycki EE, Bergman GF, Furr CE, Tyre C, Carlson JL, Galloway JR, Blumberg JB, Ziegler TR. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 2000;72:181-189
39. High KP, Legault C, Sinclair JA, Cruz J, Hill K, Hurd DD. Low plasma concentrations of retinol and alfa-tocopherol in hematopoietic stem cell transplant recipients: the effect of mucositis and the risk of infection. Am J Clin Nutr 2002;76:1358-1366
40. Faber M, Coudray C, Hida H, Mousseau M, Favier A. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Elem Res 1995;47:117-123
41. Melichar B, Kalabova H, Krcmova L, Urbánek L, Hyspler R, Malirova E, Solichova D. Serum alpha-tocopherol, retinol and neopterin during paclitaxel/carboplatin chemotherapy. Anticancer Res 2007;27:4397-4401
42. Kennedy DD, Tucker KL, Ladas ED, Reingold SR, Blumberg J, Kelly M. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr 2004;79:1029-1036
43. Packer L, Valacchi G. Antioxidants and the response of skin to oxidative stress: vitamin eas a key indicator. Skin Pharmacol Appl Skin Physiol 2002;15:282-290
44. Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases.What is new. J Eur Acad Dermatol Venereol 2003;17:663-669
45. Thiele JJ, Weber SU, Packer L. Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin. J Invest Dermatol 1999;113:1006-1010